432 related articles for article (PubMed ID: 29361466)
21. Omics for the future in asthma.
Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
[TBL] [Abstract][Full Text] [Related]
22. Omics sciences and precision medicine in thyroid cancer.
Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
[TBL] [Abstract][Full Text] [Related]
23. The Age of Omics-Driven Precision Medicine.
McColl ER; Asthana R; Paine MF; Piquette-Miller M
Clin Pharmacol Ther; 2019 Sep; 106(3):477-481. PubMed ID: 31407329
[No Abstract] [Full Text] [Related]
24. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
25. Integration of Omics and Phenotypic Data for Precision Medicine.
Zhao J; Feng Q; Wei WQ
Methods Mol Biol; 2022; 2486():19-35. PubMed ID: 35437716
[TBL] [Abstract][Full Text] [Related]
26. Lessons and Applications of Omics Research in Diabetes Epidemiology.
Yu G; Tam HCH; Huang C; Shi M; Lim CKP; Chan JCN; Ma RCW
Curr Diab Rep; 2024 Mar; 24(3):27-44. PubMed ID: 38294727
[TBL] [Abstract][Full Text] [Related]
27. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
28. Multi-omics study for interpretation of genome-wide association study.
Akiyama M
J Hum Genet; 2021 Jan; 66(1):3-10. PubMed ID: 32948838
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics: Applications and Promise in Mycobacterial Disease.
Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
[TBL] [Abstract][Full Text] [Related]
30. Omics sciences and precision medicine in prostate cancer.
Medori MC; Micheletti C; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Calogero AE; Cannarella R; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):95-103. PubMed ID: 37994753
[TBL] [Abstract][Full Text] [Related]
31. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
32. Not your average joint: Towards precision medicine in psoriatic arthritis.
Castillo R; Scher JU
Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
[TBL] [Abstract][Full Text] [Related]
33. Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.
Kobeissy FH; Gulbakan B; Alawieh A; Karam P; Zhang Z; Guingab-Cagmat JD; Mondello S; Tan W; Anagli J; Wang K
OMICS; 2014 Feb; 18(2):111-31. PubMed ID: 24410486
[TBL] [Abstract][Full Text] [Related]
34. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
[TBL] [Abstract][Full Text] [Related]
35. Omics-based biomarkers: current status and potential use in the clinic.
Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J
Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490
[TBL] [Abstract][Full Text] [Related]
36. How Omics Data Can Be Used in Nephrology.
Rhee EP
Am J Kidney Dis; 2018 Jul; 72(1):129-135. PubMed ID: 29478865
[TBL] [Abstract][Full Text] [Related]
37. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
[TBL] [Abstract][Full Text] [Related]
38. Improved drug therapy: triangulating phenomics with genomics and metabolomics.
Monte AA; Brocker C; Nebert DW; Gonzalez FJ; Thompson DC; Vasiliou V
Hum Genomics; 2014 Sep; 8(1):16. PubMed ID: 25181945
[TBL] [Abstract][Full Text] [Related]
39. The Application of Omics Technologies in the Research of Neurotoxicology.
Shao W; Li H
Methods Mol Biol; 2021; 2326():143-154. PubMed ID: 34097266
[TBL] [Abstract][Full Text] [Related]
40. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
